Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioArctic AB Class B (DE:B9A)
BERLIN:B9A
BioArctic AB Class B (B9A) Stock Price & Analysis
9 Followers
B9A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€15.79 - €28.40
Previous Close€20.12
Volume0.00
Average Volume (3M)197.00
Market Cap
€1.82B
Enterprise Value€1.74B
Total Cash (Recent Filing)kr863.16M
Total Debt (Recent Filing)kr10.16M
Price to Earnings (P/E)―
Beta-0.38
Next Earnings
Aug 29, 2024EPS Estimate
-€0.07Last Dividend Ex-Date
May 10, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding88,180,675
10 Day Avg. Volume0
30 Day Avg. Volume197
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioArctic AB Class B News
B9A FAQ
What was BioArctic AB Class B’s price range in the past 12 months?
BioArctic AB Class B lowest stock price was €15.79 and its highest was €28.40 in the past 12 months.
What is BioArctic AB Class B’s market cap?
Currently, no data Available
When is BioArctic AB Class B’s upcoming earnings report date?
BioArctic AB Class B’s upcoming earnings report date is Aug 29, 2024 which is in 57 days.
How were BioArctic AB Class B’s earnings last quarter?
BioArctic AB Class B released its earnings results on May 17, 2024. The company reported -€0.061 earnings per share for the quarter, beating the consensus estimate of -€0.073 by €0.012.
Is BioArctic AB Class B overvalued?
According to Wall Street analysts BioArctic AB Class B’s price is currently Overvalued.
Does BioArctic AB Class B pay dividends?
BioArctic AB Class B pays a Notavailable dividend of €0.13 which represents an annual dividend yield of N/A. See more information on BioArctic AB Class B dividends here
What is BioArctic AB Class B’s EPS estimate?
BioArctic AB Class B’s EPS estimate is -€0.07.
How many shares outstanding does BioArctic AB Class B have?
Currently, no data Available
What happened to BioArctic AB Class B’s price movement after its last earnings report?
BioArctic AB Class B reported an EPS of -€0.061 in its last earnings report, beating expectations of -€0.073. Following the earnings report the stock price went down -1.444%.
Which hedge fund is a major shareholder of BioArctic AB Class B?
Currently, no hedge funds are holding shares in DE:B9A
---
BioArctic AB Class B Stock Smart Score
Company Description
BioArctic AB Class B
BioArctic AB is a research-based biopharmaceutical company. It is primarily focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of revenue from Asia.
---
B9A Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---